Xiangxue Pharmaceutical Co., Ltd. (300147)
Market Closed
10 Aug, 06:57
XSHE XSHE Primary ¥
7. 61
-0.19
-2.4359%
¥
6.37B Market Cap
- P/E Ratio
0.18% Div Yield
9.12M Volume
- Eps
¥ 7.8
Previous Close Want to track 300147 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
300147 closed yesterday lower at ¥7.61, a decrease of -2.4359% from Friday's close, completing a monthly decrease of -20.1469% or -¥1.92. Over the past 12 months, 300147 stock lost -17.1024%.
300147 is not paying dividends to its shareholders.
The last earnings report, released on Oct 26, 2024, missed the consensus estimates by -0.1254%. On average, the company has fell short of earnings expectations by -0.1102%, based on the last three reports.
Xiangxue Pharmaceutical Co., Ltd. has completed 5 stock splits, with the recent split occurring on Jun 18, 2015.
The company's stock is traded on one exchange.
300147 Chart
People also search for
Xiangxue Pharmaceutical Co., Ltd. (300147) FAQ
What is the stock price today?
The current price is ¥7.61.
On which exchange is it traded?
Xiangxue Pharmaceutical Co., Ltd. is listed on XSHE.
What is its stock symbol?
The ticker symbol is 300147.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0.18%.
What is its market cap?
As of today, the market cap is 6.37B.
Has Xiangxue Pharmaceutical Co., Ltd. ever had a stock split?
Xiangxue Pharmaceutical Co., Ltd. had 5 splits and the recent split was on Jun 18, 2015.
Xiangxue Pharmaceutical Co., Ltd. Profile
| Biotechnology Industry | Healthcare Sector | Mr. Yonghui Wang CEO | XSHE Exchange | CNE100000Y92 ISIN |
| CN Country | 2,769 Employees | 23 Jun 2020 Last Dividend | 18 Jun 2015 Last Split | 15 Dec 2010 IPO Date |
Overview
Xiangxue Pharmaceutical Co., Ltd., founded in 1997 and headquartered in Guangzhou, China, operates within the pharmaceutical industry, focusing on the research, development, procurement, manufacture, delivery, and distribution of pharmaceutical products across China. The company is recognized for its Xiangxue brand name, under which it offers antivirotic oral liquids among other healthcare supplements. Moreover, Xiangxue Pharmaceutical has embraced the digital era by establishing a strategic partnership with 111, Inc. This collaboration aims to innovate and develop the "Internet + Medicine" model, specifically tailored for advancing the traditional Chinese medicine sector within the dynamic marketplace of China.
Products and Services
- Antivirotic Oral Liquids - Under the Xiangxue brand name, these products offer a promising solution against viral infections, catering to the healthcare needs of individuals seeking effective and reliable antiviral treatment options.
- Healthcare Supplements - Xiangxue Pharmaceutical extends its product line to include various healthcare supplements, aimed at improving overall health and well-being through a range of vitamins, minerals, and other beneficial compounds.
- Health Solutions in Food and Beverage - Beyond conventional pharmaceuticals, Xiangxue harnesses the integration of health solutions within food and beverage products. This innovative approach seeks to deliver health benefits seamlessly integrated into daily consumption patterns.
Contact Information
Address: No. 2 Jinfengyuan Road, Guangzhou, China, 510663
Phone: 86 20 2221 1555
Website: https://www.xphcn.com
